SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 33 filers reported holding SINOVAC BIOTECH LTD in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $104,000 | – | 26,429 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAIF Advisors Ltd | 10,780,820 | $405,359,000 | 85.85% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 1.34% |
| Orbimed Advisors | 2,839,500 | $72,000,000 | 0.67% |
| Yorktown Management & Research Co Inc | 74,893 | $485,000 | 0.40% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.36% |
| Financial Gravity Asset Management, Inc. | 123 | $798,000 | 0.02% |
| Freedom Investment Management, Inc. | 34,898 | $117,000 | 0.01% |
| Skandinaviska Enskilda Banken AB (publ) | 40,000 | $259,000 | 0.00% |
| Renaissance Technologies | 2,375,841 | $1,537,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,922 | $0 | 0.00% |